financetom
Business
financetom
/
Business
/
Advanced Micro Devices Poised for Earnings Boost From OpenAI Deal, Oppenheimer Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Advanced Micro Devices Poised for Earnings Boost From OpenAI Deal, Oppenheimer Says
Oct 7, 2025 7:58 AM

10:42 AM EDT, 10/07/2025 (MT Newswires) -- Advanced Micro Devices' ( AMD ) earnings growth is likely to accelerate following the chipmaker's multiyear partnership with Microsoft ( MSFT ) -backed OpenAI, Oppenheimer said in a note emailed Tuesday.

Under the agreement, AMD will deploy 6 gigawatts of its graphics processing units to power OpenAI's artificial intelligence infrastructure, with the first GW deployment due in the second half of next year. The parent of generative AI chatbot ChatGPT received a warrant to purchase up to 160 million of AMD's shares, reflecting a stake of up to 10%.

The brokerage now projects AMD's earnings of $6.40 per share in calendar year 2026 and $9.26 in 2027, up from prior estimates of $5.97 and $7.89, respectively. Analysts polled by FactSet expect adjusted EPS of $6.05 next year and $8.14 in 2027.

On an analyst call on Monday, AMD Chief Executive Lisa Su said the deal's structure will be "highly accretive" to revenue growth and earnings.

"From a revenue standpoint, revenue begins in the second half of 2026 and adds double-digit billions of annual incremental data center AI revenue once it ramps," she said, according to a FactSet transcript. "And it also gives us clear line of sight to achieve our initial goal of tens of billions of dollars of annual data center AI revenue starting in 2027."

The deal is a "long-awaited validation" of AMD's AI efforts, Oppenheimer analysts, including Rick Schafer, said. "Investors welcomed the deal, as it adds some certainty to AMD's uncertain AI ramp," Schafer wrote.

AMD shares were up 5.5% in Tuesday trade, adding to a 24% rally following the deal's announcement on Monday. The stock has surged 77% so far this year.

Schafer said he would review AMD's estimates after the company's third-quarter results, scheduled for release on Nov. 4. The brokerage maintained its perform rating, while awaiting more clarity on the deal's incremental contribution.

The agreement is expected to yield "dollar content" exceeding $15 billion per GW at an average selling price of $22,000 to $24,000, according to the Oppenheimer report.

Initial revenue from the accord is expected in the second half of 2026, with full ramp anticipated in the following year, Schafer said.

Price: 214.16, Change: +10.45, Percent Change: +5.13

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Coca-Cola Appoints Matthew Blickley as CFO
Coca-Cola Appoints Matthew Blickley as CFO
Jan 10, 2025
09:07 AM EST, 01/10/2025 (MT Newswires) -- Coca-Cola (COKE) said Friday that Matthew Blickley has been appointed as chief financial officer, starting April 1. Blickley will succeed Scott Anthony, who will retire effective March 31, the company said. Blickley currently serves as the senior vice president of financial planning and chief accounting officer, and will retain his responsibilities as chief...
WisdomTree Reports December Assets Under Management of $109.78 Billion
WisdomTree Reports December Assets Under Management of $109.78 Billion
Jan 10, 2025
09:04 AM EST, 01/10/2025 (MT Newswires) -- WisdomTree ( WT ) reported Friday assets under management in December of $109.78 billion. The company said inflows were $543 million in US Equity, $180 million in Cryptocurrency, and $26 in Alternatives. Significant outflows included $376 million in Fixed Income, $365 million in Emerging Market Equity, and $165 million in Commodity & Currency,...
Revvity Secures FDA Clearance for Automated Free Testosterone Test
Revvity Secures FDA Clearance for Automated Free Testosterone Test
Jan 10, 2025
09:06 AM EST, 01/10/2025 (MT Newswires) -- Revvity ( RVTY ) said Friday the Food and Drug Administration has cleared EUROIMMUN's automated chemiluminescence-based immunoassay test, which is used for measuring free testosterone levels. The test is the first FDA-cleared assay for direct measurement of free testosterone in human serum or plasma, the company said. Revvity ( RVTY ) said that...
Beer Maker Constellation Brands' Q3 Sales Hit By Subdued Spending; Stock Slides
Beer Maker Constellation Brands' Q3 Sales Hit By Subdued Spending; Stock Slides
Jan 10, 2025
Constellation Brands Inc ( STZ ) shares are trading lower after the company reported nearly flat third-quarter sales of $2.46 billion, missing the analyst consensus estimate of $2.53 billion. Net sales for the Beer segment increased 3% Y/Y to $2.03 billion, and Wine and Spirits declined 14% to $431.4 million. Shipment volume for Beer climbed 1.6%, while Wine and Spirits...
Copyright 2023-2026 - www.financetom.com All Rights Reserved